Depletion of p75NTR in Schwann Cells Driven by Inflammation Mediates Cutaneous Pain in Psoriasis

  • Adv Sci (Weinh). 2026 Jun;13(34):e23189. doi: 10.1002/advs.202523189.
Yibo Wang  1 Linlin Xu  1 Chenglong Pan  2 Ruonan Cao  2 Piao Zeng  1 Xinxing Lyu  3 Qingxia Hu  2 Zhenzhen Yan  1 Shuhong Huang  2 Ningning Dang  1
Affiliations
  • 1. Department of Dermatology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • 2. School of Clinical and Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • 3. Hospital For Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Abstract

Skin pain is a common but poorly understood symptom of psoriasis, affecting only a subset of patients. Using imiquimod and interleukin-17A-induced psoriasiform mouse models that exhibited pain-like behaviors, we found that nerve growth factor (NGF) levels were elevated in lesional skin, activating TrkA signaling in dorsal root ganglion neurons and promoting Schwann-cell hypertrophy. Normally, Schwann cells (SCs) limit NGF signaling in cutaneous peripheral nerves through the p75NTR receptor. However, inflammation driven by interleukin-17A increased non-muscle Myosin II activity and elevated NGF levels, leading to the internalization and degradation of p75NTR. The resulting depletion of p75NTR caused local NGF accumulation, excessive TrkA activation, and heightened pain sensitivity. These findings reveal that psoriatic inflammation converts SCs from protective buffers into drivers of pain, offering a mechanistic explanation for why only some patients experience cutaneous pain in psoriasis.

Keywords
NGF; cutaneous pain; p75NTR; psoriasis; schwann cell.
Products
Inhibitors & Agonists